Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous-Reference-Cited by-同舟云学术

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Published:2019-02-15 Issue:1 Volume:14 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Nieder Carsten^ORCID,Guckenberger Matthias,Gaspar Laurie E.,Rusthoven Chad G.,De Ruysscher Dirk,Sahgal Arjun,Nguyen Timothy,Grosu Anca L.,Mehta Minesh P.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-019-1237-9.pdf

Reference36 articles.

1. Hartgerink D, van der Heijden B, De Ruysscher D, Postma A, Ackermans L, Hoeben A, Anten M, Lambin P, Terhaag K, Jochems A, Dekker A, Schoenmaekers J, Hendriks L, Zindler J. Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions. Front Oncol. 2018;8:154. https://doi.org/10.3389/fonc.2018.00154 .

2. Frega S, Bonanno L, Guarneri V, Conte P, Pasello G. Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): towards a less dismal future? Crit Rev Oncol Hematol. 2018;128:19–29. https://doi.org/10.1016/j.critrevonc.2018.05.013 .

3. Trifiletti DM, Sheehan JP, Grover S, Dutta SW, Rusthoven CG, Kavanagh BD, Sahgal A, Showalter TN. National trends in radiotherapy for brain metastases at time of diagnosis of non-small cell lung cancer. J Clin Neurosci. 2017;45:48–53. https://doi.org/10.1016/j.jocn.2017.08.028 .

4. Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases. Clin Transl Oncol. 2017;19(9):1141–6. https://doi.org/10.1007/s12094-017-1651-0 .

5. Jeene PM, de Vries KC, van Nes JGH, Kwakman JJM, Wester G, Rozema T, Braam PM, Zindler JD, Koper P, Nuyttens JJ, Vos-Westerman HA, Schmeets I, Niël CGHJ, Hutschemaekers S, van der Linden YM, Verhoeff JJC, Stalpers LJA. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014. Acta Oncol. 2018;57(5):637–43. https://doi.org/10.1080/0284186X.2017.1418534 .

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort;Current Oncology;2024-03-21

2. Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review;Clinics and Practice;2023-11-30

3. How we treat octogenarians with brain metastases;Frontiers in Oncology;2023-08-08

4. Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?;Seminars in Radiation Oncology;2023-04

5. Brain Metastases;Target Volume Definition in Radiation Oncology;2023